Inovio Pharmaceuticals, Inc. is a pharmaceutical company. The provided filing excerpt is an auditor consent (Exhibit 23.1) from Ernst & Young LLP rather than a business description, so specific product and operational details are not available from this text. The company maintains multiple equity incentive plans including the 2007 Omnibus Incentive Plan, 2016 Omnibus Incentive Plan, 2022 Inducement Plan, and 2023 Omnibus Incentive Plan.
Q2 FY2026 — expected 2026-08-09
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-12 | 2025-12-31 | 0001055726-26-000008 | EDGAR | 74K words |
| 2025-03-18 | 2024-12-31 | 0001055726-25-000012 | EDGAR | — |
| 2024-03-06 | 2023-12-31 | 0001055726-24-000011 | EDGAR | — |
| 2023-03-01 | 2022-12-31 | 0001055726-23-000010 | EDGAR | — |
| 2022-03-01 | 2021-12-31 | 0001055726-22-000008 | EDGAR | — |
| 2021-03-01 | 2020-12-31 | 0001055726-21-000018 | EDGAR | — |
| 2020-03-12 | 2019-12-31 | 0001055726-20-000012 | EDGAR | — |
| 2019-03-12 | 2018-12-31 | 0001055726-19-000012 | EDGAR | — |
| 2018-03-14 | 2017-12-31 | 0001055726-18-000014 | EDGAR | — |
| 2017-03-15 | 2016-12-31 | 0001055726-17-000013 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-10 | 2025-09-30 | 0001055726-25-000063 | EDGAR | 47K words |
| 2025-08-12 | 2025-06-30 | 0001055726-25-000055 | EDGAR | — |
| 2025-05-13 | 2025-03-31 | 0001055726-25-000026 | EDGAR | — |
| 2024-11-14 | 2024-09-30 | 0001055726-24-000052 | EDGAR | — |
| 2024-08-08 | 2024-06-30 | 0001055726-24-000046 | EDGAR | — |
| 2024-05-13 | 2024-03-31 | 0001055726-24-000020 | EDGAR | — |
| 2023-11-09 | 2023-09-30 | 0001055726-23-000055 | EDGAR | — |
| 2023-08-09 | 2023-06-30 | 0001055726-23-000051 | EDGAR | — |
| 2023-05-10 | 2023-03-31 | 0001055726-23-000030 | EDGAR | — |
| 2022-11-08 | 2022-09-30 | 0001055726-22-000055 | EDGAR | — |
| 2022-08-09 | 2022-06-30 | 0001055726-22-000049 | EDGAR | — |
| 2022-05-10 | 2022-03-31 | 0001055726-22-000034 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-04-06 | 0001193125-26-142885 | EDGAR | 22K words |
| 2026-04-02 | 0001193125-26-138870 | EDGAR | — |
| 2026-03-12 | 0001055726-26-000009 | EDGAR | — |
| 2026-01-27 | 0001193125-26-024431 | EDGAR | — |
| 2025-12-29 | 0001193125-25-332322 | EDGAR | — |
| 2025-11-12 | 0001193125-25-275721 | EDGAR | — |
| 2025-11-10 | 0001055726-25-000064 | EDGAR | — |
| 2025-08-12 | 0001055726-25-000056 | EDGAR | — |
| 2025-07-07 | 0001193125-25-155830 | EDGAR | — |
| 2025-05-22 | 0001055726-25-000045 | EDGAR | — |
316 total filings indexed. 284 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001055726 |
| Ticker | INO |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Headquarters | San Diego, California |
| Website | https://www.inovio.com |
| Listed | 1998-12-08 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report